PTLF OTC
Petlife Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: -50.0%
YTD: +0.0%
1Y: +0.0%
3Y: -95.0%
5Y: -32.2%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$23M
-514.5% ▼
Net Income
-$23M
-530.8% ▼
EPS (Diluted)
$-0.33
+17.5% ▲
EBITDA
-$23M
-520.4% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $222K | $60K | $221K | $0 | $0 |
| Gross Profit | -$222K | -$60K | -$221K | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $73K | $0 | $0 | $0 |
| SG&A Expenses | $692K | $1M | $2M | $4M | $22M |
| Operating Expenses | $1M | $1M | $2M | $4M | $23M |
| Operating Income | -$2M | -$2M | -$2M | -$4M | -$23M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $108K | $0 | $0 | $0 | $384K |
| Income Before Tax | -$2M | -$2M | -$2M | -$4M | -$23M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$1M | -$2M | -$2M | -$4M | -$23M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-11.95 | $-0.20 | $-0.17 | $-0.40 | $-0.33 |
| EBITDA | -$1M | -$2M | -$2M | -$4M | -$23M |
| Shares Outstanding | 97246 | 8M | 11M | 9M | 69M |